ResearcherInstitut Gustave RoussyActive in the last 2 years

Mélanie Debiais

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-5566-9740; OpenAlex author ID A5118975568. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2026: 1 paper

Papers 1

Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatment. Co-author DOI 10.1016/j.ejca.2025.116160 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Anthony Tarabay · 1 shared paper, 2026 · strength 0.25
- Paper Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatment. DOI 10.1016/j.ejca.2025.116160 ↗
Cristina Smolenschi · 1 shared paper, 2026 · strength 0.25
- Paper Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatment. DOI 10.1016/j.ejca.2025.116160 ↗
Antoine Hollebecque · 1 shared paper, 2026 · strength 0.25
- Paper Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatment. DOI 10.1016/j.ejca.2025.116160 ↗
Alice Boilève · 1 shared paper, 2026 · strength 0.25
- Paper Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatment. DOI 10.1016/j.ejca.2025.116160 ↗
Michel Pierre Ducreux · 1 shared paper, 2026 · strength 0.25
- Paper Metastatic pancreatic adenocarcinoma: Real-world efficacy of first line treatment. DOI 10.1016/j.ejca.2025.116160 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.